News

Surprise US FDA approval for United Thera’s Orenitram ER for PAH

Surprise US FDA approval for United Thera’s Orenitram ER for PAH

23-12-2013

In what was seen by some observers as unexpected, the US Food and Drug Administration has approved United…

BiotechnologyNorth AmericaOrenitramRegulationRespiratory and PulmonaryTreprostinilUnited Therapeutics

Sandoz challenges United Thera’s Remodulin patents

06-02-2012

US drugmaker United Therapeutics (Nasdaq: UTHR) says that it has received a Paragraph IV Certification…

GenericsNorth AmericaNovartisPatentsPharmaceuticalRegulationRemodulinRespiratory and PulmonarySandozUnited Therapeutics

United Thera’s oral PAH drug treprostinil fails in Ph III study

26-08-2011

US biotech firm United Therapeutics (Nasdaq: UTHR) says that preliminary results from its FREEDOM-C(2)…

BiotechnologyRegulationResearchRespiratory and PulmonaryTreprostinilUnited Therapeutics

COMPANY SPOTLIGHT

Menarini

Back to top